Aug 30, 2019
Our Latest Features and News
The summer holidays may be almost over, but here at MediSieve, we’ve been keeping very busy.
Here’s a recap on just some of our activity:
Relocate Global recently published an article titled ‘Preparing for the future: inspiring students to study STEM’. When talking about students who have gone on to achieve successful STEM-related careers, Dr George Frodsham was named. Read the article here.
LDNConnected featured our latest accolade. Dr George Frodsham, recently won the Early Career Impact Award at the BBSRC Innovator of the Year Awards 2019. The award was presented by Chris Skidmore MP, Minister of State for Universities, Science, Research and Innovation at a glamorous awards ceremony in the Science Museum, London. Read the article here.
Dr Frodsham recently spoke with the National Institute for Health Research (NIHR) on how their grant has been instrumental in helping us to prepare for our first-in-man clinical study. Read more here.
We were thrilled to be featured in the South East Business Magazine on our grants to help fight Sepsis. View the feature on page 7 here.
About Magnetic Blood Filtration
MediSieve's Magnetic Blood Filtration Platform is intended to enable the rapid and specific depletion of specific agents from the bloodstream of patients. The extracorporeal therapy uses therapeutic Magnetic Beads that are designed to bind specifically to the clinical target. The Beads are introduced into the extracorporeal circuit during the therapy, mixing with the patient’s blood and binding to the clinical targets. The Delivery Platform captures all the Magnetic Beads and bound targets, preventing their return to the patient.
About MediSieve
MediSieve is a London-based BioTech start-up that has developed Magnetic Blood Filtration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. The company is a spin-off from University College London and is developing its products at the White City Innovation District in West London. MediSieve is actively seeking investment and partnerships.
MEDIA CONTACT:
Alina Kagermazova
INVESTOR AND PARTNERSHIP CONTACT:
George Frodsham
